Key result
The PLATO trial's reported paradoxical excess mortality requires independent verification to reveal further opportunities to improve outcomes in patients with acute coronary syndrome.
Key points are not available for this paper at this time.
Design
Editorial
This is an editorial discussing a viewpoint on mortality data from the PLATO trial in patients with acute coronary syndrome.
No takes yet. Share an insight, caveat, or question.
Becker et al. (2011) studied this question. The PLATO trial's reported paradoxical excess mortality requires independent verification to reveal further opportunities to improve outcomes in patients with acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: